Clinical Trials in Rio de Janeiro, Rio de Janeiro
80 recruiting
Showing 1–20 of 65 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
GM1 GangliosidosisGM2 GangliosidosisNiemann-Pick Type C Disease
Azafaros B.V.147 enrolled37 locationsNCT07054515
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
Niemann-Pick Type C Disease
Azafaros B.V.72 enrolled34 locationsNCT07082725
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
Gangliosidoses, GM2Gangliosidosis, GM1
Azafaros B.V.75 enrolled36 locationsNCT07082543
Recruiting
Phase 4
Asciminib Roll-over Study
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals347 enrolled85 locationsNCT04877522
Recruiting
Phase 3
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.150 enrolled45 locationsNCT07144163
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled381 locationsNCT05253651
Recruiting
Phase 2
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Chagas Disease
Novartis Pharmaceuticals130 enrolled20 locationsNCT06632600
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Chronic Inflammatory Demyelinating Polyneuropathy
Dianthus Therapeutics256 enrolled168 locationsNCT06858579
Recruiting
Phase 3
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Novartis Pharmaceuticals106 enrolled130 locationsNCT05755386
Recruiting
Phase 2
Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil
Congenital Syphilis
University of California, Los Angeles500 enrolled4 locationsNCT07189208
Recruiting
Not Applicable
Inspiratory Muscle Training in Hospitalized Heart Failure Patients
Heart FailureHospitalizationsInspiratory Capacity+1 more
CAROLINA NIGRO DI LEONE30 enrolled2 locationsNCT07108231
Recruiting
Phase 2
Inhaled DMT for Major Depressive Disorder
SuicideSuicidal IdeationMajor Depression+2 more
Universidade Federal do Rio Grande do Norte140 enrolled5 locationsNCT07562191
Recruiting
BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
CancerChronic Kidney DiseaseCardiovascular and Cerebrovascular Diseases+2 more
Hospital Alemão Oswaldo Cruz743 enrolled9 locationsNCT07118683
Recruiting
Not Applicable
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
HemodialysisOxidative StressKidney Failure, Chronic
Universidade Federal Fluminense30 enrolled1 locationNCT06438445
Recruiting
Not Applicable
Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients
Chronic Kidney Diseases
Universidade Federal Fluminense25 enrolled1 locationNCT06286748
Recruiting
Not Applicable
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
HypertensionInflammationCardiovascular Diseases (CVD)
Universidade Federal Fluminense34 enrolled1 locationNCT06917131
Recruiting
Not Applicable
Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Cardiovascular DiseasesHypertensionChronic Kidney Diseases
Universidade Federal Fluminense153 enrolled2 locationsNCT06288204
Recruiting
Phase 3
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia - Heterozygous
Novartis Pharmaceuticals60 enrolled66 locationsNCT06597019
Recruiting
Not Applicable
Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Chronic Kidney DiseaseKidney DiseaseInflammation+1 more
Universidade Federal Fluminense40 enrolled1 locationNCT07597005
Recruiting
Not Applicable
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
Cardiovascular DiseasesInflammationDyslipidemias
Universidade Federal Fluminense48 enrolled1 locationNCT06183307